NGI-1, also knowns ML414, is a a cell-permeable inhibitor of oligosaccharyltransferase (OST).
For research use only. We do not sell to patients.
Name | NGI-1 |
---|---|
Iupac Chemical Name | 5-(dimethylsulfamoyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-(pyrrolidin-1-yl)benzamide |
Synonyms | NGI-1; NGI1; NGI 1; ML414; ML 414; ML-414 |
Molecular Formula | C17H22N4O3S2 |
Molecular Weight | 394.51 |
Smile | O=C(NC1=NC=C(C)S1)C2=CC(S(=O)(N(C)C)=O)=CC=C2N3CCCC3 |
InChiKey | QPKGRLIYJGBKJL-UHFFFAOYSA-N |
InChi | InChI=1S/C17H22N4O3S2/c1-12-11-18-17(25-12)19-16(22)14-10-13(26(23,24)20(2)3)6-7-15(14)21-8-4-5-9-21/h6-7,10-11H,4-5,8-9H2,1-3H3,(H,18,19,22) |
CAS Number | 790702-57-7 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Off-white solid to white solid |
---|---|
Purity | >98% |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |